Trial Profile
A Double-Blind, Placebo-Controlled Cross-Over Study In Fibromyalgia Subjects To Examine Effects Of Pregabalin On Brain Response To Mechanical Pain As Assessed By Functional Magnetic Resonance Imaging, Proton Magnetic Resonance Spectroscopy And Subjective Ratings
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Fibromyalgia
- Focus Pharmacodynamics
- Sponsors Pfizer
- 13 May 2021 Results of an exploratory study from two cross-over double-blind studies (NCT00793520 and NCT00793520 ) in FM patients participated: published in the Arthritis and Rheumatology
- 27 Jan 2016 Results of additional analysis (n=16)published in the Arthritis and Rheumatology
- 19 May 2012 Effects on visual activation results presented at the 31st Annual Scientific Meeting of the American Pain Society.